drugset / Trial / NCT03187015
A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the effect of Entinostat on the bioavailability of Midazolam. The primary objective is to evaluate the effect of a single oral dose of entinostat on the pharmacokinetics (PK) of a single oral dose of midazolam in healthy subjects. The secondary objective is to evaluate the safety and tolerability of combined administration of entinostat and midazolam in healthy subjects.
Timeline
- Start
- 2017-05-23
- Primary completion
- 2017-06-04
- Completion
- 2017-08-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entinostat | Small molecule | 5 mg | Oral |
| Subject | Midazolam | Small molecule | 2 mg | Oral |
Indications
No indication recorded.